Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients

Br J Haematol. 2020 Mar;188(5):740-744. doi: 10.1111/bjh.16242. Epub 2019 Oct 14.

Abstract

This study used Korean national data to investigate the relationship between treatment patterns and outcomes in Korean adolescent and young-adult (AYA) acute lymphoblastic leukaemia (ALL) patients. Chemotherapy incorporating L-asparaginase was considered paediatric-inspired (PI), as opposed to adult protocols. In total, 65·3% of patients received PI therapy. Five-year overall survival (OS) of PI-treated patients outperformed adult protocols (63·1% vs. 40·4%; P < 0·0001); this trend was maintained within various age subgroups. Younger age, L-asparaginase therapy, and radiotherapy corresponded with superior OS by multivariable analysis. OS tends to improve with PI protocols that include L-asparaginase in AYA ALL, suggesting that therapy protocol is critical in the treatment performance of this group.

Keywords: Treatment outcome; acute lymphoblastic leukaemia; adolescents; asparaginase; young adults.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Asian People
  • Asparaginase / administration & dosage*
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Republic of Korea / epidemiology
  • Young Adult

Substances

  • Asparaginase